shortage of tirzepatide FDA reconsidering its decision to take off its drug list Concerns Surrounding Compounded GLP-1s Mount

dose reductions of these medications should be considered

Individual participant data will be shared in data sets in a deidentified and anonymised format

Your provider cannot properly monitor your response if they do not know what you are actually doing

Patients may also wish to avoid carbohydrates entirely, labelling them as categorically bad. Its important to convey to patients that these macronutrients are crucial for human health

Yes, most cases of loose stools associated with tirzepatide resolve spontaneously as the body adapts to the medication, typically within the first few weeks of treatment or after dose increases